Suppr超能文献

患者报告结局指标在成人心脏移植患者中的预后价值:一项系统评价

Prognostic value of patient-reported outcome measures in adult heart-transplant patients: a systematic review.

作者信息

Villa Bernardo Perez, Alotaibi Sultan, Brozzi Nicolas, Spindler Kurt P, Navia Jose, Hernandez-Montfort Jaime

机构信息

Heart and Vascular Institute, Cleveland Clinic Florida, Weston, FL, USA.

Heart Center, Segeberger Kliniken GmbH, Bad Segeberg, Germany.

出版信息

J Patient Rep Outcomes. 2022 Mar 16;6(1):23. doi: 10.1186/s41687-022-00431-4.

Abstract

BACKGROUND

The aim of this systematic review was to describe the prognostic value of patient-reported outcome measures (PROMs) in adult heart-transplant (HT) patients.

METHODS

A systematic search was performed on Ovid Medline, CINAHL Plus, Web of Science, and PubMed. The study protocol was registered on the PROSPERO database (CRD42021225398), and the last search was performed on January 7, 2021. We included studies of adult HT patients where generic and disease-specific PROMs were used as prognostic indicators for survival, readmissions, HT complications, and the onset of new comorbidities. We excluded studies that used clinician-reported and patient-experience outcomes. The Quality in Prognosis Studies tool (QUIPS) was used to measure the risk of bias of the included studies.

RESULTS

We included five observational studies between 1987 and 2015, whose populations' mean age ranged from 43 to 56 years and presented a higher proportion of males than females. The Kansas City Cardiomyopathy Questionnaire demonstrated a negative correlation with readmissions (coefficient = - 1.177, p = 0.031), and the EQ-5D showed a negative correlation with the onset of neuromuscular disease after HT (coefficient = - 0.158, p < 0.001). The Millon Behavioral Health Inventory and the Nottingham Health Profile demonstrated a statistically significant association as survival predictors (p = 0.002 and p < 0.05, respectively). A moderate overall risk of bias was reported in three studies, one study resulted in a low risk of bias, and a proportion of more than 75% of males in each of the studies. High heterogeneity between the studies impeded establishing a link between PROMs and prognostic value.

CONCLUSION

There is low evidence supporting PROMs usage as prognostic tools in adult HT patients. Comparing outcomes of PROMS to routine prognostic in wider and systematic settings is warranted. Systematic use of PROMs in clinical settings is warranted.

摘要

背景

本系统评价的目的是描述患者报告结局测量指标(PROMs)在成人心脏移植(HT)患者中的预后价值。

方法

在Ovid Medline、CINAHL Plus、Web of Science和PubMed上进行了系统检索。研究方案已在PROSPERO数据库(CRD42021225398)中注册,最后一次检索于2021年1月7日进行。我们纳入了使用通用和疾病特异性PROMs作为生存、再入院、HT并发症和新合并症发生的预后指标的成人HT患者研究。我们排除了使用临床医生报告结局和患者体验结局的研究。使用预后研究质量工具(QUIPS)来衡量纳入研究的偏倚风险。

结果

我们纳入了1987年至2015年间的五项观察性研究,其人群平均年龄在43至56岁之间,男性比例高于女性。堪萨斯城心肌病问卷与再入院呈负相关(系数=-1.177,p=0.031),EQ-5D与HT后神经肌肉疾病的发生呈负相关(系数=-0.158,p<0.001)。米隆行为健康量表和诺丁汉健康概况作为生存预测指标显示出统计学上的显著关联(分别为p=0.002和p<0.05)。三项研究报告了中度的总体偏倚风险,一项研究的偏倚风险较低,且每项研究中男性比例均超过75%。研究之间的高度异质性阻碍了建立PROMs与预后价值之间的联系。

结论

几乎没有证据支持将PROMs用作成人HT患者的预后工具。有必要在更广泛和系统的环境中将PROMs的结果与常规预后进行比较。有必要在临床环境中系统地使用PROMs。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验